Utah Medical Products Other Operating Income or Expenses 2010-2025 | UTMD
Utah Medical Products other operating income or expenses from 2010 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
| Utah Medical Products Annual Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Utah Medical Products Quarterly Other Operating Income or Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2019-03-31 | |
| 2018-12-31 | |
| 2018-09-30 | |
| 2018-06-30 | |
| 2018-03-31 | |
| 2017-12-31 | |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.173B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.485B | 27.83 |
| Boston Scientific (BSX) | United States | $154.809B | 38.76 |
| Stryker (SYK) | United States | $144.946B | 30.31 |
| EssilorLuxottica (ESLOY) | France | $134.105B | 0.00 |
| Medtronic (MDT) | Ireland | $108.260B | 15.35 |
| Haleon (HLN) | United Kingdom | $50.025B | 28.46 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.059B | 0.00 |
| ResMed (RMD) | United States | $36.038B | 27.07 |
| GE HealthCare Technologies (GEHC) | United States | $31.860B | 15.13 |
| Agilent Technologies (A) | United States | $31.051B | 20.51 |
| Terumo (TRUMY) | Japan | $27.450B | 35.65 |
| Insulet (PODD) | United States | $22.837B | 89.64 |
| Koninklijke Philips (PHG) | Netherlands | $22.023B | 15.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.348B | 11.78 |
| Baxter (BAX) | United States | $15.616B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.578B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.204B | 21.59 |
| Lantheus Holdings (LNTH) | United States | $5.198B | 13.11 |
| Prestige Consumer Healthcare (PBH) | United States | $4.172B | 18.64 |
| Perrigo (PRGO) | Ireland | $3.700B | 9.38 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.362B | 14.64 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Envista Holdings (NVST) | United States | $2.820B | 23.44 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.000B | 13.76 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.647B | 0.00 |
| Neogen (NEOG) | United States | $1.350B | 17.28 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.223B | 12.41 |
| Kestra Medical Technologies (KMTS) | United States | $1.186B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| BioLife Solutions (BLFS) | United States | $1.049B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.05 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.634B | 0.00 |
| Evolus (EOLS) | United States | $0.618B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Owens & Minor (OMI) | United States | $0.531B | 4.40 |
| Valneva SE (VALN) | France | $0.527B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.508B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.436B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.338B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.315B | 11.58 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.20 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.237B | 10.78 |
| Biote (BTMD) | United States | $0.212B | 5.95 |
| Brainsway (BWAY) | Israel | $0.196B | 52.00 |
| OraSure Technologies (OSUR) | United States | $0.190B | 0.00 |
| Quanterix (QTRX) | United States | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.07 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.085B | 10.96 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| United Health Products (UEEC) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.44 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.29 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |